Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short vs long course beraprost sodium for diabetic proteinuria
ChiCTR2000035794Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Aug 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of beraprost in diabetic glomerulosclerosis and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoint: Urine protein. Planned start Aug 2020; status: not yet recruiting.
02
Drugs
beraprost
03
Conditions
diabetic glomerulosclerosistype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR2000035794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000035794.